dr. schadendorf on the efficacy of targeted therapy plus checkpoint inhibitors
Published 6 years ago • 218 plays • Length 1:40Download video MP4
Download video MP3
Similar videos
-
3:10
targeted therapy or checkpoint inhibitors in melanoma: which is better?
-
1:38
dr. schadendorf on nivolumab/ ipilimumab combination trial in melanoma
-
2:41
dr. roy herbst describes the efficacy of immune checkpoint inhibitors
-
1:03
integrating immunotherapy and targeted therapy with tace in uhcc treatment
-
13:53
immune checkpoint inhibitors & co-stimulatory molecules | presented by dr. philippe bedard
-
1:15
targeted immunotherapy in cancer
-
1:24
dr. schadendorf discusses sequencing agents in melanoma
-
5:48
how do checkpoint inhibitors and targeted therapies work together to treat kidney cancer?
-
12:52
what is immunotherapy?
-
57:18
webinar - pd-1/pd-l1 inhibitors: the first wave of immuno-oncology
-
12:12
immune checkpoint proteins
-
0:52
dr. stein on targeted therapies for melanoma
-
1:40
pros and cons of immune checkpoint inhibitors for tumor immunotherapy
-
8:15
single vs dual checkpoint inhibition in melanoma
-
10:44
immunotherapy: simple in theory
-
45:59
immune checkpoint inhibitors in solid tumours
-
4:38
emerging checkpoint inhibitors for hnscc
-
6:56
emerging immunotherapy combinations for melanoma
-
1:28
dr. flaig on immune checkpoint inhibitors in advanced bladder cancer
-
3:30
side effects of immune checkpoint inhibitors
-
4:27
looking to the future of melanoma
-
3:51
checkpoint inhibitors in hnscc